Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy

Jones, H.; Cooper, P.; Miller, V.; Brooks, N.; Whorwell, P. J.
October 2006
Gut;Oct2006, Vol. 55 Issue 10, p1403
Academic Journal
Background: Non-cardiac chest pain (NCCP) is an extremely debilitating condition of uncertain origin which is difficult to treat and consequently has a high psychological morbidity. Hypnotherapy has been shown to be effective in related conditions such as irritable bowel syndrome where its beneficial effects are long lasting. Aims: This study aimed to assess the efficacy of hypnotherapy in a selected group of patients with angina-like chest pain in whom coronary angiography was normal and oesophageal reflux was not contributory. Patients and methods: Twenty eight patients fulfilling the entry criteria were randomised to receive, after a four week baseline period, either 12 sessions of hypnotherapy or supportive therapy plus placebo medication over a 17 week period. The primary outcome measure was global assessment of chest pain improvement. Secondary variables were a change in scores for quality of life, pain severity, pain frequency, anxiety, and depression, as well as any alteration in the use of medication. Results: Twelve of 15 (80%) hypnotherapy patients compared with three of 13 (23%) controls experienced a global improvement in pain (p=0.008) which was associated with a significantly greater reduction in pain intensity (p=0.046) although not frequency. Hypnotherapy also resulted in a significantly greater improvement in overall well being in addition to a reduction in medication usage. There were no differences favouring hypnotherapy with respect to anxiety or depression scores. Conclusion: Hypnotherapy appears to have use in this highly selected group of NCCP patients and warrants further assessment in the broader context of this disorder.


Related Articles

  • All is not lost with lansoprazole in asthma plus GERD.  // PharmacoEconomics & Outcomes News;10/22/2005, Issue 389, p12 

    Presents information on a study which focused on the effectiveness of lansoprazole in the treatment of asthma and gastro-oesophageal reflux disease. Reduction of asthma exacerbations; Differences between lansoprazole and placebo in quality of life assessment; Contribution of inhaled...

  • NUTCRACKER ESOPHAGUS: AN IDEA WHOSE TIME HAS GONE? Kahrilas, P. J. // American Journal of Gastroenterology;Feb1993, Vol. 88 Issue 2, p167 

    Introduces a series of articles about the role of gastroesophageal reflux in chest pain.

  • Research Brief: PPIs could help treat GORD.  // GP: General Practitioner;7/22/2005, p6 

    The article discusses the use of proton pump inhibitors (PPIs) for testing gastro-oesophageal reflux disease (GORD) in patients with non-cardiac chest pain. Researchers carried out a meta-analysis of six randomized, placebo-controlled trials that included 220 patients with non-cardiac chest...

  • Esophageal Mast Cell Infiltration in a 32-Year-Old Woman with Noncardiac Chest Pain. Keol Lee; Hee Jin Kwon; In Young Kim; Kwai Han Yoo; Seulkee Lee; Yang Won Min; Poong-Lyul Rhee // Gut & Liver;Jan2016, Vol. 10 Issue 1, p152 

    Noncardiac chest pain (NCCP) is one of the most common esophageal symptoms and lacks a clearly defined mechanism. The most common cause of NCCP is gastroesophageal reflux disease (GERD). One of the accepted mechanisms of NCCP in a patient without GERD has been altered visceral sensitivity. Mast...

  • Quality of Life Measurement in Gastroenterology: What Is Available? Yacavone, Robert F.; Locke, Richard; Provenzale, Dawn T.; Eisen, Glenn M. // American Journal of Gastroenterology;Feb2001, Vol. 96 Issue 2, p285 

    Monitoring and enhancement of a patient's health-related quality of life (HURL) is an important element of research and medical care. In a previous article, we provided an overview of HURL measurement. Now we will review the structure and properties of the most commonly used generic and...

  • Chronic gastrointestinal symptoms and quality of life in the Korean population. Jeong-Jo Jeong; Myung-Gyu Choi; Young-Seok Cho; Seung-Geun Lee; Jung-Hwan Oh; Jae-Myung Park; Yu-Kyung Cho; In-Seok Lee; Sang-Woo Kim; Sok-Won Han; Kyu-Yong Choi; In-Sik Chung; Jones, Roger // World Journal of Gastroenterology;11/7/2008, Vol. 14 Issue 41, p6388 

    AIM: To evaluate the prevalence of chronic gastrointestinal symptoms and their impact on health-related quality of life (HRQOL) in the Korean population. METHODS: A cross-sectional survey, using a reliable and valid Rome II based questionnaire, was performed on randomly selected residents,...

  • Alosetron Improves Quality of Life in Women With Diarrhea-Predominant Irritable Bowel Syndrome. Watson, Maria E.; Lacey, Loretto; Kong, Steven; Northcutt, Allison R.; McSorley, David; Hahn, Beth; Mangel, Allen W. // American Journal of Gastroenterology;Feb2001, Vol. 96 Issue 2, p455 

    OBJECTIVES: The aim of this study was to assess the impact of alosetron, a treatment recently approved in the United States for irritable bowel syndrome in diarrhea-predominant female patients, on health-related quality of life. METHODS: Quality of life was assessed as part of two 12-wk...

  • A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. Hutchings, H. A.; Wareham, K.; Baxter, J. N.; Atherton, P.; Kingham, J. G. C.; Duane, P.; Thomas, L.; Thomas, M.; Ch'ng, C. L.; Williams, J. G. // ISRN Gastroenterology;2011, Special section p1 

    Background. Irritable bowel syndrome (IBS) is a chronic, difficult to treat condition. The efficacy of Aloe vera in treating IBS symptoms is not yet proven. The purpose of this study was to determine if Aloe vera is effective in improving quality of life. Methods. A multicentre, randomised,...

  • Influence of Functional Bowel Disease on Outcome of Surgical Antireflux Procedures. Axelrod, David A.; Divi, Vasu; Ajluni, Majet M.; Eckhauser, Frederic E.; Colletti, Lisa M. // Journal of Gastrointestinal Surgery;Jul2002, Vol. 6 Issue 4, p632 

    Patients with gastroesophageal reflux disease (GERD) have a coexisting diagnosis of functional bowel disease (FBD) in approximately 30% of cases. Symptom improvement after surgical therapy for GERD may be less in patients with FBD when compared to patients without this coexisting problem. A...


Read the Article


Sign out of this library

Other Topics